000 01043 a2200265 4500
005 20250516150937.0
264 0 _c20130712
008 201307s 0 0 eng d
022 _a1750-8460
024 7 _a10.12968/hmed.2013.74.3.178
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatel, Amit
245 0 0 _aIs 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
_h[electronic resource]
260 _bBritish journal of hospital medicine (London, England : 2005)
_cMar 2013
300 _a178 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aFluid Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aHydroxyethyl Starch Derivatives
_xchemistry
650 0 4 _aPlasma Substitutes
_xchemistry
650 0 4 _aSepsis
_xtherapy
700 1 _aBrett, Stephen J
773 0 _tBritish journal of hospital medicine (London, England : 2005)
_gvol. 74
_gno. 3
_gp. 178
856 4 0 _uhttps://doi.org/10.12968/hmed.2013.74.3.178
_zAvailable from publisher's website
999 _c22743379
_d22743379